rotenone has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, W; Li, X; Liu, Q; Lu, X; Qian, Y; Yang, W; Zhang, T; Zhao, K | 1 |
| Bae, JM; Cho, HJ; Choi, SW; Kim, HS; Kim, JJ; Kim, SH; Kwak, HB; Lee, BK; Lee, MS; Oh, J; Yeon, JT | 1 |
2 other study(ies) available for rotenone and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Deguelin inhibits RANKL-induced osteoclastogenesis in vitro and prevents inflammation-mediated bone loss in vivo.
Topics: Animals; Bone Diseases, Metabolic; Bone Marrow Cells; Bone Resorption; Cell Differentiation; Gene Expression Regulation; Inflammation; Inflammation Mediators; Lipopolysaccharides; Macrophages; Male; Mice, Inbred C57BL; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Rotenone; Signal Transduction | 2019 |
Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression.
Topics: Animals; Animals, Newborn; Bone Morphogenetic Proteins; Bone Resorption; Cell Differentiation; Cell Line; Cells, Cultured; Down-Regulation; Growth Inhibitors; Insecticides; Male; Mice; Mice, Inbred ICR; NFATC Transcription Factors; Osteoclasts; Proto-Oncogene Proteins c-fos; RANK Ligand; Rotenone | 2010 |